Insider Stock Trading History of Broadbent Nancy C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Broadbent Nancy C since year 2005. The trader's CIK number is 1229048. At the time of this reporting, Broadbent Nancy C is the Senior VP and CFO of Orthovita Inc . (stock ticker symbol VITA). See this page for all insider trading activities at Orthovita Inc .

Note that in the past BROADBENT NANCY C also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Broadbent Nancy C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2009-11-09 VITA Orthovita Inc Buy 5,000 3.88 19,400
2009-05-26 VITA Orthovita Inc Buy 61,000 3.30 201,117
2009-05-27 VITA Orthovita Inc Buy 39,000 3.34 130,104
2008-02-08 CGPI Collagenex Pharmaceuticals Inc Option Ex 16,667 6.25 104,168
2007-08-09 CGPI Collagenex Pharmaceuticals Inc Option Ex 8,333 6.25 52,081
2007-08-09 CGPI Collagenex Pharmaceuticals Inc Sale 8,333 13.25 110,412
2006-11-06 CGPI Collagenex Pharmaceuticals Inc Option Ex 8,333 9.00 74,997
2006-11-07 CGPI Collagenex Pharmaceuticals Inc Option Ex 8,334 9.00 75,006
2006-11-06 CGPI Collagenex Pharmaceuticals Inc Sale 8,333 13.75 114,578
2006-11-07 CGPI Collagenex Pharmaceuticals Inc Sale 8,334 14.25 118,759
2006-09-25 CGPI Collagenex Pharmaceuticals Inc Option Ex 2,201 9.00 19,809
2006-09-26 CGPI Collagenex Pharmaceuticals Inc Option Ex 6,132 9.00 55,188
2006-09-25 CGPI Collagenex Pharmaceuticals Inc Sale 2,201 13.25 29,163
2006-09-26 CGPI Collagenex Pharmaceuticals Inc Sale 6,132 13.25 81,249

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Broadbent Nancy C (Senior VP and CFO of Orthovita Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.